1. Home
  2. CWH vs SNDX Comparison

CWH vs SNDX Comparison

Compare CWH & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWH
  • SNDX
  • Stock Information
  • Founded
  • CWH 1966
  • SNDX 2005
  • Country
  • CWH United States
  • SNDX United States
  • Employees
  • CWH N/A
  • SNDX N/A
  • Industry
  • CWH Retail-Auto Dealers and Gas Stations
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWH Consumer Discretionary
  • SNDX Health Care
  • Exchange
  • CWH Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • CWH 1.1B
  • SNDX 1.1B
  • IPO Year
  • CWH 2016
  • SNDX 2016
  • Fundamental
  • Price
  • CWH $16.75
  • SNDX $15.70
  • Analyst Decision
  • CWH Strong Buy
  • SNDX Strong Buy
  • Analyst Count
  • CWH 9
  • SNDX 10
  • Target Price
  • CWH $21.33
  • SNDX $38.40
  • AVG Volume (30 Days)
  • CWH 1.8M
  • SNDX 2.2M
  • Earning Date
  • CWH 10-27-2025
  • SNDX 11-04-2025
  • Dividend Yield
  • CWH 2.87%
  • SNDX N/A
  • EPS Growth
  • CWH N/A
  • SNDX N/A
  • EPS
  • CWH N/A
  • SNDX N/A
  • Revenue
  • CWH $6,318,924,000.00
  • SNDX $77,933,000.00
  • Revenue This Year
  • CWH $4.75
  • SNDX $585.73
  • Revenue Next Year
  • CWH $7.32
  • SNDX $94.17
  • P/E Ratio
  • CWH N/A
  • SNDX N/A
  • Revenue Growth
  • CWH 5.15
  • SNDX 2126.66
  • 52 Week Low
  • CWH $11.17
  • SNDX $8.58
  • 52 Week High
  • CWH $25.97
  • SNDX $22.50
  • Technical
  • Relative Strength Index (RSI)
  • CWH 46.40
  • SNDX 56.75
  • Support Level
  • CWH $16.63
  • SNDX $15.59
  • Resistance Level
  • CWH $17.98
  • SNDX $16.65
  • Average True Range (ATR)
  • CWH 0.60
  • SNDX 0.82
  • MACD
  • CWH -0.06
  • SNDX -0.24
  • Stochastic Oscillator
  • CWH 12.27
  • SNDX 21.50

About CWH Camping World Holdings Inc.

Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: